Epileptic drop attack
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Tonic - clonic seizures
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Tonic - clonic seizures
|
0.400 |
Biomarker
|
disease |
CTD_human |
Increased seizure severity and seizure-related death in mice lacking HCN1 channels.
|
20384728 |
2010 |
Depressive disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
HCN1 channels: a new therapeutic target for depressive disorders?
|
23033536 |
2012 |
Depressive disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that HCN1 protein could be a potential target for treatment of anxiety and depression disorders.
|
22884333 |
2012 |
Depressive disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
The hyperpolarization-activated cyclic nucleotide-gated channel 1(HCN1) could be inhibited by the ketamine, a drug to alleviate depression and anxiety, and regulated the BDNF expression, however, the effects of ketamine in alleviating PTSD symptoms by regulating the HCN1-related BDNF have been poorly perceived.
|
29596995 |
2018 |
Depressive disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
HCN1 channels: a new therapeutic target for depressive disorders?
|
23033536 |
2012 |
X-linked infantile spasms
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Among the four known isoforms, HCN1 is the most expressed in the neocortex and hippocampus and de novo HCN1 point mutations have been recently associated with early infantile epileptic encephalopathy.
|
29936235 |
2018 |
X-linked infantile spasms
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
|
24747641 |
2014 |
X-linked infantile spasms
|
0.320 |
Biomarker
|
disease |
CTD_human |
De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
|
24747641 |
2014 |
Febrile Convulsions
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
After experimental febrile seizures (i.e., early in the epileptogenic process), the preserved and augmented inhibition onto principal cells may lead to reduced HCN1 expression.
|
12890777 |
2003 |
Febrile Convulsions
|
0.310 |
Biomarker
|
disease |
RGD |
Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures.
|
15837575 |
2005 |
Febrile Convulsions
|
0.310 |
Biomarker
|
disease |
HPO |
|
|
|
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that HCN1 protein could be a potential target for treatment of anxiety and depression disorders.
|
22884333 |
2012 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
BEFREE |
The hyperpolarization-activated cyclic nucleotide-gated channel 1(HCN1) could be inhibited by the ketamine, a drug to alleviate depression and anxiety, and regulated the BDNF expression, however, the effects of ketamine in alleviating PTSD symptoms by regulating the HCN1-related BDNF have been poorly perceived.
|
29596995 |
2018 |
Jacksonian Seizure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased seizure severity and seizure-related death in mice lacking HCN1 channels.
|
20384728 |
2010 |
Status Epilepticus
|
0.300 |
Biomarker
|
disease |
HPO |
|
|
|
Status Epilepticus
|
0.300 |
Biomarker
|
disease |
RGD |
Together, these results show that HCN1 channelopathy begins rapidly and persists after SE, involves both transcriptional and nontranscriptional mechanisms, and may be an early contributor to epileptogenesis.
|
21976514 |
2011 |
Epilepsy, Cryptogenic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus.
|
12890777 |
2003 |
Generalized seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased seizure severity and seizure-related death in mice lacking HCN1 channels.
|
20384728 |
2010 |
Clonic Seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased seizure severity and seizure-related death in mice lacking HCN1 channels.
|
20384728 |
2010 |
Tremor, Rubral
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gabapentin treatment improves motor coordination in a mice model of progressive ataxia.
|
19747469 |
2009 |
Single Seizure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased seizure severity and seizure-related death in mice lacking HCN1 channels.
|
20384728 |
2010 |
Awakening Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus.
|
12890777 |
2003 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
|
24747641 |
2014 |